Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
US Department of Justice
Argus Health
Fish and Richardson
Fuji
Colorcon
QuintilesIMS
Queensland Health
Harvard Business School

Generated: February 19, 2018

DrugPatentWatch Database Preview

MEDIHALER-ISO Drug Profile

« Back to Dashboard

When do Medihaler-iso patents expire, and when can generic versions of Medihaler-iso launch?

Medihaler-iso is a drug marketed by 3M and is included in one NDA.

The generic ingredient in MEDIHALER-ISO is isoproterenol sulfate. There are sixteen drug master file entries for this compound. Additional details are available on the isoproterenol sulfate profile page.

US Patents and Regulatory Information for MEDIHALER-ISO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m MEDIHALER-ISO isoproterenol sulfate AEROSOL, METERED;INHALATION 010375-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Queensland Health
Express Scripts
Federal Trade Commission
Moodys
US Army
Colorcon
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot